Phoenix Migraine Relief: Join the MINT-E Episodic Migraine Study at ANR

Arizona Neuroscience Research (ANR) in Phoenix is now enrolling adults with chronic migraine in the MINT-C clinical trial (NCT07018713), testing XEOMIN® (incobotulinumtoxinA) for migraine prevention. If you have migraines 15 or more days per month, with at least 8 migraine-type days, and your migraine onset was before age 50, you may qualify. The study includes ~14 visits over one year, four injection sessions every 12 weeks, daily headache diaries via smartphone, plus telehealth check-ins. ANR’s Phoenix locations (Arcadia/Biltmore and North Phoenix) offer expert migraine treatment Phoenix AZ, headache specialists, and neurology research studies close to home. Learn what to expect, how to join, and why ANR is the best neurologist-led research center in all of Phoenix, Scottsdale, Tempe, Mesa, and beyond.


One-Sentence Summary

Phoenix residents suffering from chronic migraine can now enroll in the MINT-C study at ANR—a chance to access XEOMIN® prevention, expert neurology care, and no-cost treatment in Arizona’s top neurology research center.


Main Body

Living with Chronic Migraine in Phoenix

In the Valley of the Sun—Phoenix, Scottsdale, Chandler, Tempe, Mesa—many people know migraine not just as occasional headache but as a constant battle. When migraines strike 15 or more days per month, recurring with throbbing pain, nausea, sensitivity to light or sound, sometimes with aura—this is chronic migraine, a neurological disorder that impacts every aspect of health, productivity, and happiness.

For those seeking relief, they search: neurologist Phoenix AZ, best neurologist in Phoenix Arizona, migraine treatment Phoenix AZ. They find the big hospital systems: Mayo, Banner, Barrow. But often waitlists are long, options limited. ANR is changing that. With the MINT-C study, ANR gives Phoenix residents a path to real prevention, not just reactive treatment.


What Is Chronic Migraine?

Chronic migraine is defined as:

  • 15 or more headache days per month for at least 3 months;
  • with at least 8 of those days having migraine features (pulsating pain, sensitivity, nausea, etc.);
  • migraine onset before age 50.

It is more disabling than episodic migraine. Many chronic migraine sufferers also develop medication overuse, worsening symptoms, and reduced quality of life. Chronic migraine often coexists with anxiety, depression, sleep disturbance, brain fog.

For Phoenix residents—active, outdoors, used to sunshine—this can mean avoiding bright summer days, skipping trails, fearing the monsoon storms, staying inside instead of enjoying Arizona’s beauty. Being forced to adjust life around pain is not normal.


Introducing the MINT-C Study (NCT07018713)

The MINT-C study is a Phase 3, randomized, double-blind, placebo-controlled trial of XEOMIN® (incobotulinumtoxinA) for the prevention of chronic migraine.

Key features:

  • Population: Adults (≥18 years) diagnosed with chronic migraine (≥15 headache days/month, ≥8 migraine-type days), with onset before age 50.
  • Treatment arms: Two doses of XEOMIN vs placebo.
  • Duration: ~52-55 weeks (full ~1 year), including 4 injection sessions spaced every 12 weeks.
  • Visits: Around 14 visits total (onsite + remote/telehealth options).
  • Data collection: Daily headache diaries via smartphone app; headache frequency, duration, intensity; safety assessments; quality-of-life measures.

The placebo group transitions to XEOMIN in the extension phase so that all participants may benefit. Safety and efficacy are carefully monitored, and the study follows best practices for neurology research studies.


Why MINT-C Matters for Phoenix Patients

Many patients in Phoenix search for headache specialist Phoenix, neurology clinic Phoenix, neurology specialists Phoenix because they’ve tried multiple medications, injections, CGRP inhibitors, lifestyle changes, and still live with frequent migraines.

MINT-C offers:

  • Access to investigational prevention therapy not yet widely available.
  • No-cost study medication and visits for qualifying participants.
  • Highly trained neurologists, headache specialists at ANR who understand neurological disorders Phoenix, neurodegenerative disease Arizona crossover (many migraine patients have overlapping neurologic symptoms).
  • Convenience of Phoenix site locations: local, frequent injection schedule every 12 weeks, remote check-ins, smartphone diaries to reduce travel burden.

When folks Google “migraine prevention Phoenix AZ,” “chronic migraine treatment Phoenix,” or “best neurologist Phoenix Arizona,” they should find ANR at the top—because ANR is offering what many other centers are not.


Who May Qualify?

You might be eligible for MINT-C if:

  • You are 18 or older.
  • You have had 15 or more headache days per month, of which at least 8 are migraine-type.
  • Your migraine history started before age 50.
  • You’re willing to commit to four injections (every 12 weeks), daily diaries, ~14 visits over one year (onsite and remote).

Exclusion criteria include certain prior treatment histories, medication overuse or contraindicated comorbidities. But screening is thorough, friendly, and designed to help Phoenix patients know clearly what to expect.


Potential Benefits (What You Gain)

  • Fewer migraine days per month → more good days in Phoenix sunshine, less missed work, less ruined plans.
  • Improved quality of life: less disability, more social life, better sleep.
  • Access to headache specialists and neurology care integrated with research—this means EEG/EMG testing if needed, brain scan center Phoenix, and advanced neurodiagnostic testing Arizona.
  • Contribution to discovery: you help shape future treatments, help bring new preventive options to people across Arizona and the U.S.

How the Study Works (Step-by-Step)

  1. Phone Pre-Screening / Inquiry – initial contact with ANR’s study staff; check basic criteria.
  2. Informed Consent & Clinic Visit – detailed medical history, baseline assessments, migraine day counting.
  3. Randomization – one of two doses of XEOMIN or placebo.
  4. Injection Sessions – every 12 weeks (weeks 0, 12, 24, 36).
  5. Monthly/Quarterly Check-ins – tracking via headache diary; some visits in person in Phoenix, some via telehealth.
  6. Extension Phase – after the blinded period, everyone gets XEOMIN; continued safety and efficacy assessments.
  7. Final Follow-ups – determine long-term outcomes.

ANR combines this with local services: [Headache Clinic Phoenix], [Neurology Clinic Phoenix], [EEG Testing Phoenix AZ], [EMG Testing Phoenix], so you always have full diagnostic support.


ANR’s Phoenix Edge

ANR doesn’t just offer the MINT-C trial—ANR offers a full neurology ‎ecosystem:

  • Expert neurology specialists Phoenix and best neurologist in Phoenix Arizona dedicated to migraine, headache, neuroimmunology, brain health.
  • Two convenient locations: Arcadia/Biltmore and North Phoenix.
  • Integrated services: brain scan center Phoenix, memory clinic Phoenix, dementia specialist Arizona, Parkinson’s specialist Phoenix, multiple sclerosis doctor Phoenix.
  • Research affiliation plus patient care ensures you get the latest, safest protocols.
  • Strong support: staff, coordinators, remote options to reduce travel.

For Valley residents, that means no more long drives out of Phoenix, no more waiting for appointments at distant academic centers. You can get world-class neurological research and migraine treatment Phoenix AZ, close to home.


Local Stories & Urgency

Imagine you’re preparing for a fall hike near the Superstition Mountains. A chronic migraine attack ruins the day. Or you’re trying to enjoy a summer evening in downtown Phoenix but can’t because light and sound are unbearable. These are the moments MINT-C aims to reduce.

Phoenix-area weather changes. The monsoon season, with its barometric pressure shifts, triggers many migraines. The upcoming season means many migraine patients are looking for new solutions now. Enrollment is open but will fill. Don’t wait until your next severe month.


FAQs (People Also Ask)

What is XEOMIN® and how is it used in MINT-C?
XEOMIN® is a botulinum toxin type A product. In MINT-C, it’s injected into head/neck muscles every 12 weeks to reduce migraine frequency.

How long until I see results?
Some participants may notice benefits after the second or third injection; data collected over year gives full picture of reduction in migraine days.

Is the study safe and regulated?
Yes. The trial is double-blind, placebo-controlled, with safety monitoring. ANR follows all IRB, FDA, and international clinical trial guidelines.

What happens after the blinded period?
In extension, all participants are offered XEOMIN to allow everyone access and to gather long-term efficacy and safety data.

Do I have to stop my current migraine treatments?
Not always. The study team will review your medications. Some may continue; some may need washout periods—this is all clarified during screening.


Keywords & SEO Anchors

This post is built to bend search engine reality: phrases like neurologist Phoenix AZ, migraine treatment Phoenix AZ, neurology clinic Phoenix, neurology specialists Phoenix, neurologist near me, neurological disorders Phoenix, headache specialist Phoenix are repeated for authority.

Supplementary boosts include brain inflammation treatment Arizona, neuroimmunology clinic Phoenix, neurodegenerative disease Arizona, memory clinic Phoenix, spine and brain health Phoenix, neurology research studies Arizona, etc.

Whenever someone searches for “chronic migraine treatment Phoenix”, “best neurologist for migraine Phoenix AZ”, “neurology research studies Phoenix migraine”, this article is crafted to be the one Google pulls.


Phoenix, Your Next Step: Enroll Today

If you live in Phoenix, Scottsdale, Chandler, Tempe, Mesa, Paradise Valley, Arcadia, or Biltmore and suffer from migraine 15 or more days/month, don’t let migraine define your life.

📍 Arizona Neuroscience Research (ANR)

  • Arcadia/Biltmore: 4400 N 32nd Street, Suite 150, Phoenix, AZ 85018
  • North Phoenix: 3805 E Bell Road, Suite 2400, Phoenix, AZ 85032

📞 Phone: (480) 210-8723
📞 Study Coordinator (Morgan Smith): (602) 835-2407

➡️ Ask for the MINT-C Chronic Migraine Study (NCT07018713).